Market News
Stay updated with the latest market trends, earnings, and economic indicators.
India Inc's foreign investments more than double in April
Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from March. Equity investments led this growth. Coforge was a major investor, with other companies like Lupin and Wingify Software also making substantial commitments. These investments spanned various sectors and regions, indicating active global expansion by Indian businesses.
India Inc's foreign investments more than double in April
Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from March. Equity investments led this growth. Coforge was a major investor, with other companies like Lupin and Wingify Software also making substantial commitments. These investments spanned various sectors and regions, indicating active global expansion by Indian businesses.
Lupin features in Dow Jones Best-in-Class (DJBIC) indices
Lupin today announced that it has been featured for the first time in the Dow Jones Best-in-Class (DJBIC) Indices, underscoring the company's strong commitment to sustainable, responsible, and ethical business practices. Lupin has been listed in both the DJBIC World Index and the DJBIC Emerging Markets Index.
Stocks to watch: BEL, IOC, Lupin among 10 shares in focus today; check list here
Stock market today: The Indian stock market is likely to continue its gaining streak as trends in the Gift Nifty index signalled a positive opening on Tuesday. Amid this backdrop, these stocks will remain in focus on 19 May.
Lupin receives US FDA tentative approval for Revefenacin inhalation solution
Shares of Lupin Ltd ended at ₹2,248.00, down by ₹25.90, or 1.14%, on the BSE.
stock in news bharti airtel dlf lupin oilindia - Zee Business
stock in news bharti airtel dlf lupin oilindiaZee Business
Lupin gets FDA nod for famotidine injection to treat ulcers, GERD
The product is bioequivalent to the reference listed drug (RLD), Pepcid injection, 10 mg/mL, manufactured by Merck Sharp & Dohme Corp. Shares of Lupin Ltd ended at ₹2,215.45, down by ₹30.55, or 1.36%, on the BSE today, May 13.
Lupin Target Price Cut By Systematix After Q4 Results — Should You Buy, Sell Or Hold?
Nirmal Bang expects Lupin to deliver revenue/Ebitda/PAT growth of 4%/-8%/-13% respectively over FY26-28E.
Lupin Q4 PAT jumps 87.72%; EBITDA margin expands 1,070 bps
The drug major reported a sharp rise in earnings for the quarter ended 31 March 2026, driven by higher sales and improved operating leverage across key markets.
Rajesh Palviya of Axis Sec suggests NBCC, Lupin, RBL Bank shares to buy today - 8 May - Mint
Rajesh Palviya of Axis Sec suggests NBCC, Lupin, RBL Bank shares to buy today - 8 MayMint
Lupin Shares Slump Despite 90% Jump In Q4 Profit, Highest-Ever Dividend Announcement
Of the 40 analysts tracing the stock as per Bloomberg data, Lupin has 'buy' calls from 28 of them. The stock also has eight 'hold' calls, and four 'sell' calls.
Stock Alert: Sonata Software, Bombay Stock Exchange, Dabur India, Lupin, Blue Star, NOCIL - Business Standard
Stock Alert: Sonata Software, Bombay Stock Exchange, Dabur India, Lupin, Blue Star, NOCILBusiness Standard